ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Also Cancer incidence, mortality level off after declines in 1990s.

September 12, 2003

Fox Chase Joins Plan For Free Cancer Screening

May 9, 1986

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

HHS Web Site Opens On Health Disparities

July 17, 1998

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

March 11, 2005